Union Health Minister Dr. Mansukh Mandaviya has launched the National Policy on Research and Development and Innovation in the Pharma-MedTech Sector in India, along with the Scheme for the Promotion of Research and Innovation in the Pharma-MedTech Sector (PRIP). The policy aims to transform India into a high-volume, high-value player in the global pharmaceutical market and facilitate quality, accessibility, and affordability. It focuses on regulatory improvements, incentivizing private and public investment in innovation, and creating an enabling ecosystem. The PRIP scheme, with a budget outlay of Rs 5,000 crores, aims to strengthen research infrastructure, promote industry-academia collaboration, and focus on priority areas such as New Chemical Entities, biosimilars, medical devices, and more. These initiatives aim to boost India's pharmaceutical and medical technology sectors, making them more innovative and globally competitive.